These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Radioimmunotherapy with alpha-particle emitting radionuclides. Zalutsky MR; Pozzi OR Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792 [TBL] [Abstract][Full Text] [Related]
12. Radium-223: down to the bone, and less is more. Chang AJ; Roach M Oncology (Williston Park); 2012 Apr; 26(4):342, 344. PubMed ID: 22655526 [No Abstract] [Full Text] [Related]
13. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides. Sgouros G; Hobbs R; Josefsson A Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036 [TBL] [Abstract][Full Text] [Related]
14. Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates. Dahle J; Abbas N; Bruland ØS; Larsen RH Curr Radiopharm; 2011 Oct; 4(4):321-8. PubMed ID: 22202154 [TBL] [Abstract][Full Text] [Related]
15. Radionuclide antibody-conjugates, a targeted therapy towards cancer. Kitson SL; Cuccurullo V; Moody TS; Mansi L Curr Radiopharm; 2013 Jun; 6(2):57-71. PubMed ID: 23808764 [TBL] [Abstract][Full Text] [Related]
16. Current status and perspectives in alpha radioimmunotherapy. Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629 [TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer. Allen BJ Australas Phys Eng Sci Med; 2017 Jun; 40(2):369-376. PubMed ID: 28342027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]